Transcranial Magnetic Stimulation in Treatment of Attention Deficit/Hyperactivity Disorders

计划入组 30 人 · 首次发布于 2012 年 6 月 13 日

The Effects of Health Promotion Program for the Caregivers of Attention Deficit/Hyperactivity Disorders Children

计划入组 60 人 · 首次发布于 2022 年 9 月 21 日

Weighted Blankets for Sleep Disturbance Among Children With ADHD

计划入组 340 人 · 首次发布于 2024 年 1 月 8 日

sodium hydrogen exchanger 9 inhibitors (attention deficit hyperactivity disorder)

Lisdexamfetamine(Vyvanse)

C₁₅H₂₅N₃O

Methylphenidate(Adhansia, Aptensio, Biphentin, Concerta, Cotempla, Daytrana, Foquest, Jornay, Metadate, Methylin, Quillichew, Quillivant, Relexxii, Ritalin, Tuzulby)

C₁₄H₁₉NO₂

Institute For Neurodegenerative Disorders

United States

Ascendis Pharma Growth Disorders A/S

Denmark

Alzheimer's Disease And Related Disorders Association, Inc.

United States

EMA Issues Precautionary Measures for Valproate Use in Male Patients Due to Potential Neurodevelopmental Risks

PRAC Finds Inconsistent Evidence on Paternal Valproate Neurodevelopmental Risk, Maintains Precautionary Measures

Digital Therapy MindPro1 Shows Promise in ADHD Treatment for Children